Characteristic of Red Blood Cell Profile as a Predictor of 30-Day Clinical Outcome in Ischemic Stroke Patients


  • Nathania Fadjarsugeng Duta Wacana Christian University
  • Rizaldy Taslim Pinzon Duta Wacana Christian University
  • Sugianto Sugianto Duta Wacana Christian University



Ischemic stroke is the most common type of stroke in Indonesia. Measuring inflammatory biomarkers (IL-6) is a way to predict clinical outcomes in ischemic stroke patients. However, the laboratory test is very expensive, so it requires another test that can represent the inflammation, for instance, by measuring RDW and MCV value when hospitalized. Hence, this study aims to measure RDW and MCV value of ischemic stroke patients at admission with a 30-day clinical outcome (disability). This study is a retrospective cohort that used secondary data from medical records of ischemic stroke patients in Bethesda Hospital Yogyakarta and was conducted on 105 subjects. They are divided into two groups by their mRS score in 30-day after onset, (1) the independent group (mRS score of 0- 2), (2) the dependent group (mRS score of 3-6). After that, these two groups are analyzed by an independent t-test. High RDW and low MCV value at admission increased 30-day disability risk. There was a statistically significant RDW value and 30-day clinical outcome (p=0,008), but there was no statistically significant MCV value and 30-day clinical outcome (p=0,277). 30-day clinical outcome in ischemic stroke patients can be predicted by their characteristic of red blood cell profile at admission.

Author Biographies

Nathania Fadjarsugeng, Duta Wacana Christian University

Faculty of Medicine

Rizaldy Taslim Pinzon, Duta Wacana Christian University

Faculty of Medicine

Sugianto Sugianto, Duta Wacana Christian University

Faculty of Medicine


Kementerian Kesehatan RI. Laporan Riskesdas 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan. 2018.

Ischemic Stroke [Internet]. 2020 [cited 2020 May 27]. Available from:

Aref, H. M. A., Fahmy, N.A., Khalil, S.H., et al. Role of interleukin-6 in ischemic stroke outcome. Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2020; 56(12): 1-7.

Shaafi, S., Sharifipour, E., Rahmanifar, R., Hejazi, S., Andalib, S., Nikanfar, M. et al. Interleukin-6, a reliable prognostic factor for ischemic stroke. Iran J Neurol. 2014; 13(2): 70-6.

Choudhary, S., Chowdhury, D., Mishra, T. K., Agarwal, S Temporal profile of serum levels of IL-6 in acute ischemic stroke and its relationship with stroke severity and outcome in Indian population. International Journal of Integrative Medical Sciences. 2018; 5(1): 555-60.

Bustamante, A., Sobrino, T., Giralt, D., Berrocoso, T. G., Liombart, V., Ugarriza, I. et al. Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: a systematic review and meta-analysis. J Neuroimmunology,l 2014; 274(1-2): 215-24.

Miyamoto, K., Inai, K., Takeuchi, D., Shinohara, T., Nakanishi, T. Relationships among red cell distribution width, anemia, and interleukin-6 in adult congenital heart disease. Circulation Journal. 2015; 79(5): 1100-6.

Hatamian, H., Saberi A, Pourghasem M. The relationship between stroke mortality and red blood cell parameters. Iran J Neurol. 2014; 13(4): 237-240.

Wu, T. H., Fann, J. C. Y., Chen, S. L. S., Yen, A. M. F., Wen, C. J., Lu, Y. R. et al. Gradient Relationship between Increased Mean Corpuscular Volume and Mortality Associated with Cerebral Ischemic Stroke and Ischemic Heart Disease: A Longitudinal Study on 66,294 Taiwanese. Scientific Reports. 2018; 8(1): 16517.

Quinn, T. J., Rowan, M. T., Coyte, A., Clark, A. B., Musgrave, S. D., Metcalf, A. K. et al. Pre-stroke modified Rankin Scale: Evaluation of validity, prognostic accuracy, and association with treatment. Frontiers in Neurology. 2017; 8(275): 1-7.

Harrison, J. K., McArthur, K. S., Quinn, T. J. Assessment scales in stroke: clinimetric and clinical considerations. Clinical Interventions in Aging. 2013; 8,: 201-11.

Davis, A. G., Nightingale, S., Springer, P. E., Solomons, R., Arenivas, A., Wilkinson, R. J. et al. Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis. Wellcome Open Research. 2019; 4(178): 1-15.

Salvagno, G. L., Gomar, F. S., Picanza, A., Lippi, G. Red blood cell distribution width: A simple parameter with multiple clinical applications. Critical Reviews in Clinical Laboratory Sciences. 2015; 52(2): 86-105.

Chernecky, C. C., Berger, B. J. Laboratory Tests and Diagnostic Procedures. 6th ed. Australia: Elsevier; 2013.

Sarhan, A., El-Sharkawy, K. A., Elkhatib, T. H. M. et al. Red Blood Cell Distribution Width as a Predictor of Clinical Outcome in Acute Ischemic Stroke Patients. International Journal of Clinical and Experimental Neurology. 2019; 7(1): 1–6.

Yogitha, C. and Kumar, A. S. Relationship Between Red Cell Distribution Width and Clinical Stroke Scoring Systems in Acute Ischemic Stroke. International Journal of Advanced Research (IJAR). 2019; 7: 356-60.

Turcato, G., Cappellari, M., Follador L. Red blood cell distribution width is an independent predictor of outcome in patients undergoing thrombolysis for ischemic stroke. Semin Thromb Hemost. 2017; 43: 30–5.

Kim, D. Y., Hong, D. Y., Kim, S. Y. et al. Prognostic value of red blood cell distribution width in predicting 3-month functional outcome of patients undergoing thrombolysis treatment for acute ischemic stroke. Medicine (United States). 2021; 100: 1-7.

Visentin, D. C., Cleary, M., Hunt, G. E. The earnestness of being important: Reporting non-significant statistical results. Journal of Advanced Nursing. 2020; 76: 917-9.

Lee, H. Bin, Kim, J., Oh, S. Hun., Kim, S. Heum, Kim, H. Sook, Kim, W. Chan et al. Red blood cell distribution width is associated with severity of leukoaraiosis. PLoS ONE. 2016; 11(2): 1-11.

Feng, G. H., Li, H. P., Li, Q. L. Fu, Y., Huang, R. B. Red blood cell distribution width and ischaemic stroke. Stroke and Vascular Neurology. 2017; 2(3): 172-5.

Drieu, A., Levard, D., Vivien, D., Rubio, M. Anti-inflammatory treatments for stroke: from bench to bedside. Therapeutic Advances in Neurological Disorder. 2018; 11:. 1-15.

Smith, C.J., Hulme, S., Vail, A., Heal, C., Parry-Jones, A. R., Scarth, S. et al. SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial. Stroke. 2018; 49(5): 1210-1216

Yuan, Y., Men, W., Shan, X., Zhai, H., Qiao, X., Geng, L. et al. Baicalein exerts neuropro- tective effect against ischaemic/reperfusion injury via alter- ation of NF-kB and LOX and AMPK/Nrf2 pathway. Inflammopharmacology. 2020; 28(5): 1327–41.

Liang, G., Shi, B., Luo, W, Yang, J.. The protective effect of caffeic acid on global cerebral ischemia- reperfusion injury in rats. Behavioral and Brain Functions. 2015; 11(18): 1-10.

Mondal, N. K., Behera, J., Kelly, K. E., George, A. K., Tyagi, P. K., Tyagi, N. Tetrahydrocurcumin epigenetically mitigates mitochondrial dysfunction in brain vasculature during ische- mic stroke. Neurochemistry International. 2019; 122: 120– 38.

Culafic, J. Kolarovic, J., Pezo, L., Cabarkapa, V., Nikolic, S., Stojadinovic, et al. Serum Concentration of Hepcidin as an Indicator of Iron Reserves in Children. Journal of Medical Biochemistry. 2018; 37(4): 456-64

Noguchi-Sasaki, M. Sasaki, Y., Shimonaka, Y, Mori, K., Fujimoto-Ouchi, K. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells. BMC Cancer. 2016; 16(270): 1-11.

Khongkhatithum, C., Kadegasem, P., Sasanakul, W., Thampratankul, L., Chuansumrit, A., Sirachainan, N. Abnormal red blood cell indices increase the risk of arterial ischemic stroke in children. Journal of Clinical Neuroscience. 2019; 62: 117-20.

Denorme, F. Wyseure, T., Peeters, M., Vandeputte, N., Gils, A., Deckmyn, H. et al. Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice. Stroke. 2016; 47(9): 2419-22.




How to Cite

Fadjarsugeng, N., Pinzon, R. T., & Sugianto, S. (2022). Characteristic of Red Blood Cell Profile as a Predictor of 30-Day Clinical Outcome in Ischemic Stroke Patients. Jurnal Profesi Medika : Jurnal Kedokteran Dan Kesehatan, 16(1).